In addition, an aberrant expression of MAML1 is described in esophageal squamous cell carcinoma (ESCC), human HCC and in head and neck squamous cell carcinoma, where it correlates with the clinicopathological features of tumors, predicting poor prognosis (Forghanifard et al., 2012; Wang et al., 2016; Hashemi Bidokhti et al., 2017; Ardalan Khales et al., 2018; Moghbeli et al., 2019). The gene discussed is MAML1; the disease is esophageal squamous cell carcinoma.